The role of interleukin-10 in the regulation of the systemic inflammatory response following trauma-hemorrhage.

[1]  E. Verrier,et al.  Endogenous interleukin-4 and interleukin-10 regulate experimental lung ischemia reperfusion injury. , 2003, The Annals of thoracic surgery.

[2]  L. Moldawer,et al.  ROLE OF ENDOGENOUS INTERLEUKIN‐10 IN LOCAL AND DISTANT ORGAN INJURY AFTER VISCERAL ISCHEMIA‐REPERFUSION , 2003, Shock.

[3]  D. Mosser,et al.  The many faces of macrophage activation , 2003, Journal of leukocyte biology.

[4]  Yaozhong Ding,et al.  Suppressor of Cytokine Signaling 1 Inhibits IL-10-Mediated Immune Responses 1 , 2003, The Journal of Immunology.

[5]  J. Cavaillon,et al.  Adherence influences monocyte responsiveness to interleukin‐10 , 2003, Journal of leukocyte biology.

[6]  A. Yoshimura,et al.  Involvement of Suppressor of Cytokine Signaling-3 as a Mediator of the Inhibitory Effects of IL-10 on Lipopolysaccharide-Induced Macrophage Activation1 , 2002, The Journal of Immunology.

[7]  I. Chaudry,et al.  Cyclooxygenase 2-mediated suppression of macrophage interleukin-12 production after thermal injury. , 2002, American journal of physiology. Cell physiology.

[8]  S Pestka,et al.  Differential IL-10R1 Expression Plays a Critical Role in IL-10-Mediated Immune Regulation1 , 2001, The Journal of Immunology.

[9]  D. Cohen,et al.  IL‐10 receptor dysfunction in macrophages during chronic inflammation , 2001, Journal of leukocyte biology.

[10]  I. Chaudry,et al.  Resistance of macrophages to the suppressive effect of interleukin-10 following thermal injury. , 2001, American journal of physiology. Cell physiology.

[11]  Y. Liu,et al.  Up-Regulation of IL-10R1 Expression Is Required to Render Human Neutrophils Fully Responsive to IL-101 , 2001, The Journal of Immunology.

[12]  C. Ogle,et al.  The effect of burn injury on suppressors of cytokine signalling. , 2000, Shock.

[13]  P. Giannoudis,et al.  Immediate IL-10 expression following major orthopaedic trauma: relationship to anti-inflammatory response and subsequent development of sepsis , 2000, Intensive Care Medicine.

[14]  M. Wichmann,et al.  Immune dysfunction in trauma. , 1999, The Surgical clinics of North America.

[15]  J. Lederer,et al.  Protective effects of early interleukin 10 antagonism on injury-induced immune dysfunction. , 1999, Archives of surgery.

[16]  W. Alexander,et al.  Suppressors of cytokine signaling (SOCS): negative regulators of signal transduction , 1999, Journal of leukocyte biology.

[17]  J. Lederer,et al.  Interleukin 10 is not essential for survival or for modulating T-cell function after injury. , 1999, Surgery.

[18]  I. Chaudry,et al.  What is the role of interleukin 10 in polymicrobial sepsis: anti-inflammatory agent or immunosuppressant? , 1999, Surgery.

[19]  H. Dickensheets,et al.  The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[20]  H. Dickensheets,et al.  Interleukin-10 Inhibits Expression of Both Interferon – and Interferon γ– Induced Genes by Suppressing Tyrosine Phosphorylation of STAT1 , 1999 .

[21]  E. Faist,et al.  SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS), MULTIPLE ORGAN DYSFUNCTION SYNDROME (MODS), MULTIPLE ORGAN FAILURE (MOF): ARE WE WINNING THE BATTLE? , 1998, Shock.

[22]  T. Hamilton,et al.  IL‐10 suppresses LPS‐induced KC mRNA expression via a translation‐dependent decrease in mRNA stability , 1998, Journal of leukocyte biology.

[23]  J. Cone,et al.  Interleukin-10 reduces morbidity and mortality in murine multiple organ dysfunction syndrome (MODS) , 1998 .

[24]  G. Gerken,et al.  Interleukin‐10 expression is autoregulated at the transcriptional level in human and murine kupffer cells , 1998, Hepatology.

[25]  Wei Wu,et al.  Identification and functional characterization of a second chain of the interleukin‐10 receptor complex , 1997, The EMBO journal.

[26]  J. Lederer,et al.  Anti-interleukin-10 antibody restores burn-induced defects in T-cell function. , 1997, Surgery.

[27]  Warren S. Alexander,et al.  A family of cytokine-inducible inhibitors of signalling , 1997, Nature.

[28]  U. Steckholzer,et al.  Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. , 1997, The Journal of trauma.

[29]  I. Chaudry,et al.  Mechanism of splenic immunosuppression during sepsis: key role of Kupffer cell mediators. , 1997, The Journal of trauma.

[30]  J. Reynolds,et al.  Interleukin-10. A role in the development of postoperative immunosuppression. , 1997 .

[31]  M. McCarter,et al.  Dominance of T-helper 2-type cytokines after severe injury. , 1996, Archives of surgery.

[32]  R. Bone,et al.  Sir Isaac Newton, sepsis, SIRS, and CARS. , 1996, Critical care medicine.

[33]  J. Dipiro,et al.  Interleukin-10 is associated with the development of sepsis in trauma patients. , 1996, The Journal of trauma.

[34]  I. Chaudry,et al.  Trauma-induced suppression of antigen presentation and expression of major histocompatibility class II antigen complex in leukocytes. , 1996, Shock.

[35]  E. Radwanski,et al.  Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers. , 1996, Blood.

[36]  H. Volk,et al.  Lipopolysaccharide‐induced interleukin‐10 in mice: role of endogenous tumor necrosis factor‐α , 1995, European journal of immunology.

[37]  R. Donnelly,et al.  Inhibition of IL-10 expression by IFN-gamma up-regulates transcription of TNF-alpha in human monocytes. , 1995, Journal of immunology.

[38]  L. Moldawer,et al.  Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses , 1995, The Journal of experimental medicine.

[39]  I. Chaudry,et al.  Mechanism of enhanced susceptibility to sepsis following hemorrhage. Interleukin-10 suppression of T-cell response is mediated by eicosanoid-induced interleukin-4 release. , 1994, Archives of surgery.

[40]  M. Billah,et al.  IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. , 1994, Journal of immunology.

[41]  Z. Ba,et al.  ROLE OF KUPFFER CELLS IN INTERLEUKIN‐6 RELEASE FOLLOWING TRAUMA‐HEMORRHAGE AND RESUSCITATION , 1994, Shock.

[42]  M. Howard,et al.  Interleukin 10 protects mice from lethal endotoxemia , 1993, The Journal of experimental medicine.

[43]  Y. Vodovotz,et al.  Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. , 1992, The Journal of biological chemistry.

[44]  E. Deitch,et al.  Multiple organ failure. Pathophysiology and potential future therapy. , 1992, Annals of surgery.

[45]  E. Shevach,et al.  IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. , 1992, Journal of immunology.

[46]  I. Chaudry,et al.  Hemorrhage induces enhanced Kupffer cell cytotoxicity while decreasing peritoneal or splenic macrophage capacity. Involvement of cell-associated tumor necrosis factor and reactive nitrogen. , 1991, Journal of immunology.

[47]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[48]  C G Figdor,et al.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.

[49]  T. Mosmann,et al.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones , 1989, The Journal of experimental medicine.

[50]  D. Remick,et al.  Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. , 1988, The Journal of biological chemistry.

[51]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[52]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[53]  S. Akira,et al.  Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. , 1999, Immunity.

[54]  T. van der Poll,et al.  Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13. , 1997, The Journal of infectious diseases.

[55]  E. Faist.  The mechanisms of host defense dysfunction following shock and trauma. , 1996, Current topics in microbiology and immunology.

[56]  I. Chaudry,et al.  Differential effects of hemorrhage on Kupffer cells: decreased antigen presentation despite increased inflammatory cytokine (IL-1, IL-6 and TNF) release. , 1992, Cytokine.